| Dr Katrina Sanders, MD | |
|
83 Herrick St, Suite 2004, Beverly, MA 01915-2757 | |
| (978) 927-4800 | |
| (978) 232-5772 |
| Full Name | Dr Katrina Sanders |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 83 Herrick St, Beverly, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265412902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 226305 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Hospital Corporation | Beverly, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Essex County Obgyn Assoc Inc | 6204829062 | 20 |
News Archive
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced a new application process for its major block grant programs - the Substance Abuse Prevention and Treatment Block Grant and the Community Mental Health Services Block Grant. The change is designed to provide states greater flexibility to allocate resources for substance abuse and mental illness prevention, treatment and recovery services in their communities.
The research team, directed by Joseph Gleeson, M.D., Director of the Neurogenetics Laboratory at the UCSD School of Medicine and associate professor in the Department of Neurosciences, have identified a new gene that, when mutated, leads to JSRD. Their findings will be published on-line in advance of publication in the journal Nature Genetics.
Zyga Technology, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the company's request to update the indications for use of its SImmetry Sacroiliac Joint Fusion System.
An interview with Brendan O'Brien from Vision Direct, discussing everything from the types of contact lenses available to preventing 'dry eye' and the future potential of smart lenses!
› Verified 3 days ago
| Entity Name | Essex County Obgyn Assoc Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538275870 PECOS PAC ID: 6204829062 Enrollment ID: O20040407000041 |
News Archive
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced a new application process for its major block grant programs - the Substance Abuse Prevention and Treatment Block Grant and the Community Mental Health Services Block Grant. The change is designed to provide states greater flexibility to allocate resources for substance abuse and mental illness prevention, treatment and recovery services in their communities.
The research team, directed by Joseph Gleeson, M.D., Director of the Neurogenetics Laboratory at the UCSD School of Medicine and associate professor in the Department of Neurosciences, have identified a new gene that, when mutated, leads to JSRD. Their findings will be published on-line in advance of publication in the journal Nature Genetics.
Zyga Technology, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the company's request to update the indications for use of its SImmetry Sacroiliac Joint Fusion System.
An interview with Brendan O'Brien from Vision Direct, discussing everything from the types of contact lenses available to preventing 'dry eye' and the future potential of smart lenses!
› Verified 3 days ago
| Entity Name | Northeast Medical Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235147760 PECOS PAC ID: 2365405024 Enrollment ID: O20050111000265 |
News Archive
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced a new application process for its major block grant programs - the Substance Abuse Prevention and Treatment Block Grant and the Community Mental Health Services Block Grant. The change is designed to provide states greater flexibility to allocate resources for substance abuse and mental illness prevention, treatment and recovery services in their communities.
The research team, directed by Joseph Gleeson, M.D., Director of the Neurogenetics Laboratory at the UCSD School of Medicine and associate professor in the Department of Neurosciences, have identified a new gene that, when mutated, leads to JSRD. Their findings will be published on-line in advance of publication in the journal Nature Genetics.
Zyga Technology, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the company's request to update the indications for use of its SImmetry Sacroiliac Joint Fusion System.
An interview with Brendan O'Brien from Vision Direct, discussing everything from the types of contact lenses available to preventing 'dry eye' and the future potential of smart lenses!
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katrina Sanders, MD 83 Herrick St, Suite 2004, Beverly, MA 01915-2757 Ph: (978) 927-4800 | Dr Katrina Sanders, MD 83 Herrick St, Suite 2004, Beverly, MA 01915-2757 Ph: (978) 927-4800 |
News Archive
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced a new application process for its major block grant programs - the Substance Abuse Prevention and Treatment Block Grant and the Community Mental Health Services Block Grant. The change is designed to provide states greater flexibility to allocate resources for substance abuse and mental illness prevention, treatment and recovery services in their communities.
The research team, directed by Joseph Gleeson, M.D., Director of the Neurogenetics Laboratory at the UCSD School of Medicine and associate professor in the Department of Neurosciences, have identified a new gene that, when mutated, leads to JSRD. Their findings will be published on-line in advance of publication in the journal Nature Genetics.
Zyga Technology, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the company's request to update the indications for use of its SImmetry Sacroiliac Joint Fusion System.
An interview with Brendan O'Brien from Vision Direct, discussing everything from the types of contact lenses available to preventing 'dry eye' and the future potential of smart lenses!
› Verified 3 days ago
Deborah Bradley, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 83 Herrick St, Suite 2004, Beverly, MA 01915 Phone: 978-927-4800 Fax: 978-232-5772 | |
Dr. Shiloe Souza Burzinski, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 83 Herrick St Ste 2004, Beverly, MA 01915 Phone: 978-927-4800 Fax: 978-777-4792 | |
Linda Kleeman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 75 Herrick St Ste 114, Beverly, MA 01915 Phone: 978-922-3000 | |
Laurel A Bauer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 83 Herrick Street, Suite 2004, Beverly, MA 01915 Phone: 978-927-4800 Fax: 978-232-5772 | |
Melissa Jane Sherman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 83 Herrick St, Suite 2004, Beverly, MA 01915 Phone: 978-927-4800 Fax: 978-232-5772 | |
Cara L Chuderewicz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 83 Herrick Street, Suite 2004, Beverly, MA 01915 Phone: 978-927-4800 Fax: 978-232-5772 |